The largest Czech biotechnology company Sotio has announced that it has passed another milestone in the search for drugs to fight malignant tumors. One of the preparations of the company, which belongs to the PPF financial group, has successfully passed initial tests and is entering the first phase of clinical testing on patients. This is already the third product that Sotio has in one of the phases of human testing. The company is primarily involved in the development of drugs against cancer.
The real estate division of the PPF Group has experience with the international company Hines from London and Moscow. PPF Real Estate is newly buying the New City office complex from Warsaw, thanks to which the company is expanding its operations to Poland. The value of the transaction was not disclosed after the agreement of both parties.
Contact Us
Do You Have Any Questions?
Tereza Matejkova
+420 210 012 566
Validation
Your choice regarding cookies on this site
We use cookies to optimise site functionality and give you the best possible experience.
This site uses cookies to store information on your computer.
Some of these cookies are essential, while others help us to improve your experience by providing insights into how the site is being used.
Accept Recommended Settings
Necessary Cookies
Necessary cookies enable core functionality such as page navigation and access to secure areas. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytics
Analytical cookies help us to improve our website by collecting and reporting information on its usage.
Marketing
We use marketing cookies to help us improve the relevancy of advertising campaigns you receive.
Social Sharing Cookies
We use some social sharing plugins, to allow you to share certain pages of our website on social media.
